Skip to main content
. 2024 Jun 21;111(1):771–780. doi: 10.1097/JS9.0000000000001862

Figure 1.

Figure 1

(A) comparison of changes in relevant clinical indications before and after surgery. (B) comparison of changes in relevant postoperative clinical indications between adverse events and no adverse events. Adverse event definitions include death, heart failure (HF), ventricular arrhythmic composite, and recurrent left ventricular outflow tract obstruction (LVOTO). Ventricular arrhythmic composite was defined as patients experiencing sudden cardiac death (SCD), resuscitated cardiac arrest, or appropriate implantable cardioverter-defibrillator (ICD) therapy. HF composite was defined as patients who appear with LV ejection fraction (EF) <35%, New York Heart Association (NYHA) class III/IV symptoms, heart transplantation (HTx), or left ventricular assist device (LVAD) implantation. Recurrent LVOTO refers to obstruction occurring (instantaneous peak Doppler left ventricular outflow tract pressure gradients >30 mmHg) at least 60 days after surgery. SAM, systolic anterior motion; LVOT, left ventricular outflow tract. Pre-Op: pre-operation; Post-op: post-operation. Degree of SAM:0: none, 1: partial, 2: complete.